Guidance for Holmes Biopharma, Inc. (LMB)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2024 | N/A | N/A | $510.00M – 530.00M | $541.10M | = Maintained | Details |
| 2023 | N/A | N/A | $490.00M – 520.00M | $529.00M |  Lowered |
Details |
| 2023 | N/A | N/A | $490.00M – 520.00M | $495.70M | = Maintained | Details |
| 2023 | N/A | N/A | $490.00M – 520.00M | $501.00M | = Maintained | Details |
| 2021 | N/A | N/A | $480.00M – 520.00M | $539.65M | = Maintained | Details |
| 2021 | N/A | N/A | $480.00M – 510.00M | $490.00M | = Maintained | Details |
| 2020 | N/A | N/A | $560.00M – 600.00M | $567.46M | = Maintained | Details |
| 2020 | N/A | N/A | $560.00M – 600.00M | $536.30M | = Maintained | Details |
| 2019 | N/A | N/A | $560.00M | $562.50M | = Maintained | Details |
| 2019 | N/A | N/A | $550.00M – 570.00M | $559.85M | = Maintained | Details |
| 2019 | N/A | N/A | $560.00M | $559.98M | = Maintained | Details |
| 2018 | N/A | N/A | $530.00M – 550.00M | $527.77M | = Maintained | Details |
| 2018 | N/A | N/A | $530.00M – 550.00M | $541.82M | = Maintained | Details |
| Q2 2018 | N/A | N/A | $520.00M – 540.00M | $520.67M | = Maintained | Details |
| 2017 | N/A | N/A | $460.00M – 480.00M | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | $460.00M – 470.00M | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | $460.00M – 480.00M | $478.53M | = Maintained | Details |
